BSEBoard Meeting3 Aug 2026 · 3 Aug 2026, 02:52 pm
Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1.To consider and approve ....
Sandu Pharmaceuticals Ltd · 524703
✦ AI SummaryResults
Sandu Pharmaceuticals Ltd has scheduled a board meeting on 11th August 2026 to consider and approve the standalone unaudited financial results for the quarter ended 30th June 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sandu Pharmaceuticals Ltd - 524703 - Board Meeting Intimation for To Consider And Approve The Standalone Unaudited Financial Results Of The Company For The Quarter Ended 30Th June, 2026.
Attachments (1)
📄pdf
Download →
2d9bd763-5f4e-4ad1-b062-278863688bea.pdf
View document text
%u __ SANDU PHARMACEUTICALS LIMITED
CIN:L24233GA1985PLC001587
SAMDU
m Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511.
Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in
Ref No: SPL/Corp.Sec/2026-27/464
Dated:03.08.2026
Department of Corporate Services
Bombay Stock Exchange Limited,
Phirojshah Jeejobhoy tower,
Dalal Street,
Mumbai-400001.
Sub: Intimation about Board Meeting 29 & 30 of SEBI (Listing Obligation and Disclosure
Requirements) Regulation 2015
ScripCode:524703
Respected Sir
‘We would like to inform you that a Meeting of the Board of Directors of the Company will be held
on Tuesday, the 11th day of August 2026 at 04:00 p.m at the Corporate Office of the Company at
Sandu Pharmaceuticals Limited, Sandu Nagar, D K Sandu Marg, Chembur, Mumbai 400 071 to
consider the following
0 To consider and approve the Standalone Unaudited Financial Results of the Company for the
quarter ended 30th June, 2026.
O To consider any other matter with the permission of the Chair.
This notice is being submitted pursuant to Regulation 29 of the Securities & Exchange Board of
India (Listing Regulations and Disclosure Requirements) Regulation 2015.
In Compliance with the Company’s Code of Conduct for prevention of Insider Trading devised as
per the SEBI (Prohibition of Insider Trading) we would also like to inform that the trading window
for dealing in the Securities of the Company has been closed for the Company’s Directors/Officer
and designated employees of the Company from the opening of Trading hours on Wednesday, 01%
day of July 2026 till 48 hours after announcement of financial results to public for the Quarter
ended 30" June 2026 in compliances with the code of conduct for prevention of Insider Trading
Regulation 2015.
You are requested to kindly take note of the same.
ThanKing you,
Yours Faithfully,
FOR SANDU PHARMACEUTICALS LIMITED.
Pratika Mhambray
Company Secretary & Compliance Officer
A:36512
AN ISO 9001:2015 CERTIFIED ORGANISATION
Corporate Office: P B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai - 400 071
Tel.: +91 22 2528 4402 / 3306, E-mail: info@sandu.in